Cholesterol Drug Testing Comes To A Halt
foxreno.com     22-May-2008            

Merck stops a study of what it hoped would be a new way to treat high cholesterol. ... Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after... [read full story]                    


View all news articles about*:
Ambulatory America Care Cholesterol Drugs Health Jersey KGaA Medical Medicines Merck North Patients Pharmaceuticals Remedies Research States Trenton United
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Merck, Schering-Plough face Vytorin probe

pharmiweb.co.uk     5 hrs ago   66 related          

U.S. committee wants Merck, Schering-Plough to answer questions Committee's letter says it got only a five-page report Questions relate to safety of cholesterol drug Vytorin One clinical study indicated the drug has a...                    

comments

                   

Merck Serono and Ablynx Enter Into an Agreement to Co-Discover and Co-Develop Nanobodies(R)

pharmiweb.co.uk     8 hrs ago   5 related          

Merck Serono and Ablynx to Equally Contribute to Discover and Develop Nanobodies(R) Against two Targets in Oncology and Immunology and Equally Share the Resulting Profits GENEVA, SWITZERLAND | September 4, 2008 | Merck...                    

comments

                   

Suicide Risk Of Certain Drugs Under FDA Investigation

pharmiweb.co.uk     19 hrs ago          

Federal investigators are currently investigating claims that certain drugs prescribed for asthma, controlling seizures or quitting smoking may be linked to a high risk of suicide. Some two months later, the company that...                    

comments

Biovail files ANDA for fenofibrate tablets

pharmiweb.co.uk     7 hrs ago   4 related          

US-based specialty pharmaceutical company Biovail has announced that the FDA has accepted the company's abbreviated new drug application for a generic formulation of 145mg and 48mg strengths of fenofibrate tablets, sold...                    

comments